logo
Plus   Neg
Share
Email

Merck: European Commission Approves KEYTRUDA, Inlyta Combination To Treat RCC

Merck (MRK) said the European Commission has approved KEYTRUDA combined with Inlyta for the first-line treatment of patients with advanced renal cell carcinoma. The company noted that this is the first anti-PD-1 therapy approved as Part of a combination regimen in Europe for renal cell carcinoma across all IMDC risk groups. The approval was based on data from KEYNOTE-426 trial.

Merck said the approval allows marketing of the KEYTRUDA combination in all 28 EU member states plus Iceland, Lichtenstein and Norway.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ride hailing company Uber Technologies Inc. is cutting 600 jobs in India amid the impact of continuing coronavirus-related lockdown across the country, reports said citing Uber India and South Asia President Pradeep Parameswaran. The affected employees include full-time workers in driver and rider support, as well as other functions, and represent around 25 percen of its workforce in the country. Conagra Brands, Inc. is recalling approximately 276,872 pounds of not ready-to-eat chicken and turkey bowl products, citing the presence of extraneous materials specifically small rocks, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced in a statement. The latest recall is an expansion to the Russellville, Arkansas-based company's earlier recall in April. The German government has approved a 9 billion euros rescue package for Deutsche Lufthansa AG (DLAKF, DLAKY), which is the largest German corporate rescue package since the coronavirus crisis struck. The airline has also agreed to the rescue deal.
Follow RTT